Bausch Health
389 hedge funds and large institutions have $7.19B invested in Bausch Health in 2016 Q1 according to their latest regulatory filings, with 104 funds opening new positions, 138 increasing their positions, 104 reducing their positions, and 162 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 138 | Existing positions reduced: 104
10.03% less ownership
Funds ownership: 89.53% → 79.5% (-10%)
12% less call options, than puts
Call options by funds: $1.47B | Put options by funds: $1.68B
14% less funds holding
Funds holding: 451 → 389 (-62)
36% less first-time investments, than exits
New positions opened: 104 | Existing positions closed: 162
49% less funds holding in top 10
Funds holding in top 10: 53 → 27 (-26)
77% less capital invested
Capital invested by funds: $31B → $7.19B (-$23.8B)
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.46B |
| 2 |
BC
Brahman Capital
New York
|
-$825M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$792M |
| 4 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$593M |
| 5 |
JP Morgan Chase
New York
|
-$511M |
BHC Hedge Fund Activity: Q1 2016 in Review
389 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2016, worth a combined $7.19B — down 77% from $31B a quarter earlier.
Sellers outnumbered buyers: 162 funds closed out of BHC and 104 opened new positions — a net loss of 58 holders — while 104 trimmed existing stakes and 138 added.
The largest buyer was Nomura Holdings, adding an estimated $378M. The largest seller was T. Rowe Price Associates, cutting an estimated $1.46B.
- 389 institutional investors held Bausch Health (BHC) as of Q1 2016, down from 451 in Q4 2015.
- Funds reported $7.19B of Bausch Health stock for Q1 2016, down 77% quarter-over-quarter.
- 104 funds opened new Bausch Health positions in Q1 2016 and 162 closed out, a net change of -58 holders.
- The largest Bausch Health buyer in Q1 2016 was Nomura Holdings, an estimated $378M added.
- The largest Bausch Health seller in Q1 2016 was T. Rowe Price Associates, an estimated $1.46B sold.
Based on aggregated 13F filings for Q1 2016.